Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 1Phase 2 1

Status

Completed 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4Gastrointestinal 2Lymphoid 1Head & Neck 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 13Glioblastoma 7Breast Neoplasms 7Brain Neoplasms 7Astrocytoma 7Oligodendroglioma 6Glioma 6Neoplasms 5Gliosarcoma 5Ependymoma 5Thyroid Neoplasms 4Meningioma 4Medulloblastoma 4Lung Neoplasms 4Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Thyroid Cancer, Papillary 3Rectal Neoplasms 3Pancreatic Neoplasms 3Neuroectodermal Tumors, Primitive 3Lymphoma 3Hodgkin Disease 3Glioma, Subependymal 3Colorectal Neoplasms 3Colonic Neoplasms 3Adenocarcinoma, Follicular 3Waldenstrom Macroglobulinemia 2Pinealoma 2Optic Nerve Glioma 2Neuroblastoma 2

Interventions

Carboplatin 346Cisplatin 240Paclitaxel 208Radiotherapy 207Pemetrexed 190Docetaxel 170Gemcitabine 158pembrolizumab 147Erlotinib Hydrochloride 111Magnetic Resonance Spectroscopy 102Etoposide 99Bevacizumab 96Specimen Handling 84Nivolumab 77Radiosurgery 74durvalumab 73Blood Specimen Collection 65Drug Therapy 61osimertinib 56Vinorelbine 54Gefitinib 50Surveys and Questionnaires 48atezolizumab 45Biopsy 43Radiation 42Irinotecan 42Topotecan 39Standard of Care 39Cyclophosphamide 38Surgical Procedures, Operative 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Lung Neoplasms × 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole × Clear all
NCT02293954 2025-11-14

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

City of Hope Medical Center

Phase NA Active not recruiting
20 enrolled 8 charts
BreastGastrointestinalThoracic

Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Carcinoma, Medullary

NCT01789892 2018-06-28

Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Withdrawn
Thoracic

Lung Neoplasms

NCT00123747 2016-02-25

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer

AHS Cancer Control Alberta

Phase 2 Completed
23 enrolled
Thoracic

Lung Neoplasms

NCT00123760 2016-02-25

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

AHS Cancer Control Alberta

Phase 2/3 Completed
10,838 enrolled
CNSGastrointestinalHead & NeckLymphoidThoracic

Brain Neoplasms, Lung Neoplasms, Lymphoma, Thyroid Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡